Skip Navigation

Filter Results

1037 News Releases Found

Wayne A. Marasco, MD, PhD
News Releases
4/6/2020

Dana-Farber scientists bring experience from SARS and MERS outbreaks to aid COVID-19 research

  • Research
Identification of cancer status for more than 50 cancer types, as well as tissue of origin localization, from a single blood draw. Cell-free DNA is isolated from blood samples drawn from a patient without cancer (top) or with cancer (bottom), and subjected to a targeted methylation sequencing assay. Sequencing results identifying methylated (red) or unmethylated (blue) CpG regions are fed into a machine-learning classifier that can identify the presence or absence of cancer, as well as identify the tissue of origin (TOO).
News Releases
3/30/2020

New blood test can detect wide range of cancers, now available to at risk individuals in clinical study at Dana-Farber

  • Research
Panos A. Konstantinopoulos, MD, PhD
News Releases
3/19/2020

Scientists identify factors for predicting which patients with ovarian cancer won’t benefit from immunotherapy-PARP inhibitor combination

  • Precision Cancer Medicine
  • Immunotherapy
  • Ovarian Cancer
Heather A. Parsons, MD, MPH
News Releases
3/13/2020

Personalized blood biopsies demonstrate potential as early-warning signal of breast cancer recurrence

  • Precision Cancer Medicine
Pancreatic Cancer Cells
News Releases
3/5/2020

Dana-Farber research team awarded Pancreatic Cancer Collective “New Therapies Challenge” grant

  • Research
  • Pancreatic Cancer
_
News Releases
3/2/2020

Six new members elected to the Board at Dana-Farber Cancer Institute

Katherine A. Janeway, MD, MMSc
News Releases
2/27/2020

The Osteosarcoma Institute to Fund Clinical Trial in Recurrent Osteosarcoma at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

  • Soft Tissue Sarcomas, Childhood
  • Bone Cancers, Childhood
Jonathan D. Schoenfeld, MD, MPhil, MPH
News Releases
2/27/2020

Pre-operative immunotherapy shows promise in oral cancers

  • Immunotherapy
  • Head and Neck Cancer
Laurie H. Glimcher, MD and Ansbert Gadicke, MD (photo credit: Justin Knight, Dana-Farber Cancer Institute)
News Releases
2/26/2020

MPM Capital Announces $100M Oncology Innovations Fund as Part of Novel Venture Philanthropy Collaboration with Dana-Farber Cancer Institute  

  • Research